GNH USA

Europe — EMA

Linagliptin Krka D.D.

GNH USA supplies Linagliptin Krka D.D. (Linagliptin), a dipeptidyl peptidase‑4 (DPP‑4) inhibitor for type 2 diabetes mellitus.

Linagliptin

Request sourcing

1
Pack/s

What is Linagliptin?

Linagliptin, the active ingredient in Linagliptin Krka D.D., is a dipeptidyl peptidase‑4 (DPP‑4) inhibitor presented as a tablet for oral use. It is indicated for the management of type 2 diabetes mellitus in adult patients. GNH USA supplies Linagliptin Krka D.D. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Linagliptin used for?

Linagliptin is used within the antidiabetic drug class to improve glycaemic control in patients with type 2 diabetes mellitus.

- Type 2 diabetes mellitus: lowers blood glucose by enhancing insulin secretion and reducing glucagon release in a glucose‑dependent manner.

What are the side effects of Linagliptin?

Linagliptin is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nasopharyngitis: mild upper‑respiratory tract infection. - Headache: transient and usually mild. - Upper respiratory tract infection: cough, sore throat. - Dizziness: occasional light‑headedness. - Gastrointestinal upset: nausea or abdominal discomfort.

Serious or Rare Side Effects: - Pancreatitis: severe abdominal pain requiring immediate medical attention. - Severe allergic reactions: rash, angioedema, or anaphylaxis. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Hypoglycaemia: especially when combined with insulin or sulfonylureas.

What precautions apply to Linagliptin?

Before initiating linagliptin, consider the following safety measures.

- Renal function monitoring: use with caution in severe renal impairment. - Hepatic function assessment: avoid in patients with significant liver disease. - Hypersensitivity check: discontinue if allergic reactions occur. - Concomitant antidiabetic agents: adjust doses to prevent hypoglycaemia. - Pregnancy and lactation: safety not established; prescribe only if benefit outweighs risk. - Store at ambient temperature: keep in the original pack, protect from moisture and light.

What does Linagliptin interact with?

Linagliptin may interact with other medicines; awareness of the interaction level helps manage risk.

Major Interactions (Avoid): - Insulin or sulfonylureas: increased risk of hypoglycaemia. - Rifampin: may reduce linagliptin plasma concentrations.

Moderate Interactions (Monitor Closely): - Strong P‑gp inhibitors (e.g., itraconazole): may raise linagliptin exposure. - ACE inhibitors or ARBs: monitor renal function and potassium. - Diuretics: watch for electrolyte disturbances. - Warfarin: periodic INR checks are advisable.

Frequently asked questions

What is Linagliptin Krka D.D. used for?+
Linagliptin Krka D.D. is prescribed to improve blood‑sugar control in adults with type 2 diabetes mellitus. It works as part of a comprehensive diabetes management plan that may include diet, exercise, and other antidiabetic agents.
How does linagliptin work in the body?+
Linagliptin blocks the DPP‑4 enzyme, which normally breaks down the incretin hormones GLP‑1 and GIP. By preserving these hormones, the drug enhances insulin release and reduces glucagon output in response to meals, thereby lowering glucose levels.
What is the usual dose of linagliptin?+
The specific dose of Linagliptin Krka D.D. is determined by the prescribing clinician based on individual patient factors such as renal function, concomitant therapies, and glycaemic targets. Patients should follow the prescriber’s instructions exactly.
Is linagliptin safe during pregnancy or breastfeeding?+
Safety data for linagliptin in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.
How do I order Linagliptin Krka D.D. from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.
How does linagliptin compare with other DPP‑4 inhibitors?+
Linagliptin shares the same class mechanism as other DPP‑4 inhibitors but is distinguished by its primarily biliary excretion, allowing use without dose adjustment in most patients with renal impairment. Efficacy and safety profiles are comparable across the class.
What are the storage requirements for Linagliptin Krka D.D.?+
Store the tablets at ambient temperature, below 25 °C, in the original container. Protect them from moisture, excessive heat, and direct sunlight to maintain product stability.
How is Linagliptin Krka D.D. administered?+
Linagliptin is taken orally, usually once daily, with or without food. The tablet should be swallowed whole with water and not chewed or crushed, unless otherwise directed by a healthcare provider.
What are the most serious risks associated with linagliptin?+
Serious adverse events include pancreatitis, severe allergic reactions such as anaphylaxis, and hepatic dysfunction. Patients should seek immediate medical attention if they experience persistent abdominal pain, rash, swelling, or signs of liver injury.
Who should not use linagliptin?+
Linagliptin is contraindicated in individuals with known hypersensitivity to the drug or any of its excipients. Caution is also advised for patients with severe hepatic disease, and it should be avoided in those where the risk of hypoglycaemia cannot be safely managed.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Linagliptin
Route
Oral Use
Manufacturer
Krka, D.D., Novo Mesto
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU